<DOC>
	<DOCNO>NCT00997490</DOCNO>
	<brief_summary>The efficacy tolerability Neurapas速 balance compare placebo single-centre , control , double-blind study patient mild depressive episode . After one-week placebo run-in phase exclude placebo responder , patient give study medication ( Neurapas速 balance placebo ) 6 week dose 3 x 2 tablet daily . The improvement symptom depression assess basis internationally establish Hamilton Depression Scale 21 . The Self-Rating Depression Scale ( SDS ) , Hamilton Anxiety Scale ( HAM-A ) , Clinical Global Impressions ( CGI ) , Quality Life questionnaire ( SF-36 ) accord Bullinger ( German version ) Sleep questionnaire ( SQ ) use efficacy criterion .</brief_summary>
	<brief_title>Study Antidepressant Efficacy Combination Herbal Drug Preparation ( NEURAPAS Balance )</brief_title>
	<detailed_description>The efficacy tolerability Neurapas速 balance compare placebo single-centre , control , double-blind study patient mild depressive episode accord ICD 10 , F32.0 F33.0 . After one-week , placebo run-in phase exclude placebo responder , patient give study medication ( Neurapas速 balance placebo ) 6 week dose 3 x 2 tablet daily . The study conduct accordance relevant requirement German Medicines Act ( AMG ) , Declaration Helsinki ( 48th General Assembly , Sommerset West , Rep. South Africa , October 1996 ) ICH GCP guideline . The improvement symptom depression assess basis internationally establish Hamilton Depression Scale 21 ( primary efficacy criterion ) . The Self-Rating Depression Scale ( SDS ) , Hamilton Anxiety Scale ( HAM-A ) , Clinical Global Impressions ( CGI ) , Quality Life questionnaire ( SF-36 ) accord Bullinger ( German version ) Sleep questionnaire ( SQ ) use secondary efficacy criterion .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Depressive symptom mild intensity , define International Classification Mental Disorders ( ICD 10 ) , cod F32.0 ( mild depressive episode ) F33.0 ( recurrent depressive disorder , current episode mild ) SDS Index 51 59 ( criterion declare null void 21.02.02 2nd Amendment ) HAMD21 score 10 17 Between 18 70 year age Duration depression : le 4 week longer 2 year Signed informed consent take part clinical study verbal write information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>depression</keyword>
	<keyword>HAMD 21</keyword>
	<keyword>anxiety</keyword>
	<keyword>HAMA</keyword>
	<keyword>Hypericum</keyword>
	<keyword>Valerian</keyword>
	<keyword>Passionflower</keyword>
	<keyword>F32.0</keyword>
	<keyword>F33.0</keyword>
</DOC>